CAMP4 Therapeutics Corporations' Exciting IPO Announcement
CAMP4 Therapeutics Corporation (“CAMP4”) (NASDAQ: CAMP) has made a significant announcement regarding the pricing of its initial public offering (IPO), offering 6,820,000 shares at an opening price of $11.00 per share. This offering is entirely composed of shares being offered by CAMP4 itself. The anticipated gross proceeds from the IPO, prior to deducting any underwriting discounts, commissions, and other costs associated with the offering, are projected to be around $75.0 million.
Trading and Closing Expectations
The shares of CAMP4 are expected to commence trading on the Nasdaq Global Market under the ticker symbol “CAMP.” This milestone is particularly notable as it sets a new chapter for the company, reflecting its growth and aspirations in the biotech sector. The trading is expected to begin on a specified date in the near future, with the offering slated to close shortly after, pending customary closing conditions being met.
Underwriting Management
The company has secured reputable underwriting partnerships to manage this crucial stage. J.P. Morgan, along with Leerink Partners, Piper Sandler, and William Blair, will collectively act as joint book-running managers for the offering. Their expertise is expected to assist in navigating the complexities of this IPO and provide valuable insights into market trends.
Registration Statement and Prospectus Availability
A registration statement pertaining to the shares that are being offered has been duly filed with the U.S. Securities and Exchange Commission (“SEC”). This statement became effective shortly before the anticipated trading date. To ensure transparency, CAMP4 warns that the offering will only be conducted via a comprehensive prospectus. Potential investors interested in obtaining copies of the final prospectus can do so by reaching out to the underwriting firms directly.
Contact Information for Inquiries
Individuals seeking more information about the prospectus can contact:
- J.P. Morgan Securities LLC, at (866) 803-9204 or via email.
- Leerink Partners LLC, at (800) 808-7525 ext. 6105.
- Piper Sandler & Co., at (800) 747-3924.
- William Blair & Company, at (800) 621-0687.
These avenues provide prospective investors with the opportunity to gather necessary information to make informed investment decisions.
Important Legal Considerations
It is crucial to note that this announcement is not a solicitation to buy or sell securities nor an offer in jurisdictions where such offers would be unlawful prior to proper registration or qualification under relevant securities laws. CAMP4 encourages potential investors to review all materials and consider legal aspects before engaging in any investment activities.
Frequently Asked Questions
What is the total number of shares CAMP4 is offering?
CAMP4 is offering a total of 6,820,000 shares at an initial price of $11 per share.
When is the expected trading start date for CAMP4 shares?
The shares are anticipated to begin trading shortly, with a targeted date set for the early days of trading on Nasdaq.
Who are the underwriters for the CAMP4 IPO?
The underwriters for the IPO include J.P. Morgan, Leerink Partners, Piper Sandler, and William Blair.
How can investors obtain the prospectus for this IPO?
Investors can contact the underwriting firms directly to acquire copies of the final prospectus.
Is this announcement an offer to sell shares?
No, this announcement does not constitute an offer to sell or a solicitation to buy any securities.
